Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-09-07
Original SEC Filing: Click here

---

Webplus: SKBI/20100907/8-K_1/2_EX-99.1/000.htm SEC Original: v196098_ex99-1.htm
SKYSTAR ANNOUNCES UPDATE XI’AN, CHINA – September 7, 2010 – Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) (“Skystar” or the “Company”), Acquisition in Hubei Province The Company completed acquisition of a modern, GMP-certified veterinary medicine facility in Hubei Province on August 11, 2010. Skystar estimates the Hubei facility, located in Jingzhou, Hubei Province, will contribute about $4 million to $6 million in revenue

---

---

Webplus: SKBI/20100907/8-K_1/1/000.htm SEC Original: v196098_8k.htm
FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): September 7, 2010 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 001-34394 33-0901534 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Issuer Telephone Number) N/A (Former name or

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-09-07CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE